101 related articles for article (PubMed ID: 1084365)
1. The requirement for esterase activation in the anti-immunoglobulin-triggered movement of B lymphocytes.
Becker EL; Unanue ER
J Immunol; 1976 Jul; 117(1):27-32. PubMed ID: 1084365
[TBL] [Abstract][Full Text] [Related]
2. Organophosphorus inhibition of lysosomal enzyme secretion from polymorphonuclear leucocytes. Evidence of a lack of a requirement for esterase activation.
Becker EL; Koza EP; Sigman M
Immunology; 1978 Aug; 35(2):373-80. PubMed ID: 750374
[TBL] [Abstract][Full Text] [Related]
3. The requirement for esterase activation in T cell replacing factor (TRF)-induced IgG production in a human B blastoid cell line.
Miki Y; Kishi H; Muraguchi A; Kishimoto S; Yamamura Y; Kishimoto T
J Immunol; 1982 Feb; 128(2):675-8. PubMed ID: 6798119
[TBL] [Abstract][Full Text] [Related]
4. Ligand-induced movement of lymphocyte surface macromolecules. IV. Stimulation of cell motility by anti-Ig and lack of relationship to capping.
Unanue ER; Ault KA; Karnovsky MJ
J Exp Med; 1974 Feb; 139(2):295-312. PubMed ID: 4544022
[TBL] [Abstract][Full Text] [Related]
5. Anti-Ig-triggered movements of lymphocytes-specificity and lack of evidence for directional migration.
Schreiner GF; Unanue ER
J Immunol; 1975 Feb; 114(2 pt 2):809-14. PubMed ID: 1078680
[TBL] [Abstract][Full Text] [Related]
6. The role of immunoglobulin receptors and T cell mediators in B lymphocyte activation. I. B cell activation by anti-immunoglobulin and anti-idiotype reagents.
Primi D; Lewis GK; Goodman JW
J Immunol; 1980 Sep; 125(3):1286-92. PubMed ID: 6774015
[TBL] [Abstract][Full Text] [Related]
7. IL-4 (B cell stimulatory factor 1) overcomes Fc gamma receptor-mediated inhibition of mouse B lymphocyte proliferation without affecting inhibition of c-myc mRNA induction.
Phillips NE; Gravel KA; Tumas K; Parker DC
J Immunol; 1988 Dec; 141(12):4243-9. PubMed ID: 2974056
[TBL] [Abstract][Full Text] [Related]
8. Sequential induction of phospholipid methylation and serine esterase activation in a B cell differentiation factor (BCDF)-stimulated human B cell line.
Kishi H; Miki Y; Kikutani H; Yamamura Y; Kishimoto T
J Immunol; 1983 Oct; 131(4):1961-5. PubMed ID: 6352808
[TBL] [Abstract][Full Text] [Related]
9. Production of BSF-1 during an in vivo, T-dependent immune response.
Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
[TBL] [Abstract][Full Text] [Related]
10. Inhibition by phorbol esters of antiimmunoglobulin-induced calcium signalling and B-cell activation.
Rothstein TL; Kolber DL; Simons ER; Baeker TR
J Cell Physiol; 1986 Dec; 129(3):347-55. PubMed ID: 3491085
[TBL] [Abstract][Full Text] [Related]
11. Lyb-5- B cells of CBA/N mice can be induced to synthesize DNA by culture with insolubilized but not soluble anti-Ig.
Mond JJ; Schaefer M; Smith J; Finkelman FD
J Immunol; 1983 Nov; 131(5):2107-9. PubMed ID: 6195249
[TBL] [Abstract][Full Text] [Related]
12. Idiotypes on B lymphocytes: association with immunoglobulins.
Victor C; Bona C; Pernis B
J Immunol; 1983 Apr; 130(4):1819-25. PubMed ID: 6187821
[TBL] [Abstract][Full Text] [Related]
13. The requirement for surface Ig signaling as a prerequisite for T cell:B cell interactions. A possible role for desialylation.
Kearse KP; Cassatt DR; Kaplan AM; Cohen DA
J Immunol; 1988 Mar; 140(6):1770-8. PubMed ID: 3126236
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo B lymphocyte-activating properties of monoclonal anti-delta antibodies. I. Determinants of B lymphocyte-activating properties.
Goroff DK; Stall A; Mond JJ; Finkelman FD
J Immunol; 1986 Apr; 136(7):2382-92. PubMed ID: 2419432
[TBL] [Abstract][Full Text] [Related]
15. The role of intercellular contacts in the activation of B lymphocytes by anti-immunoglobulin antibodies.
Spieker-Polet H; Hagen K; Teodorescu M
J Immunol; 1985 May; 134(5):2827-34. PubMed ID: 3872324
[TBL] [Abstract][Full Text] [Related]
16. Characterization of antigen processing and presentation by resting B lymphocytes.
Gosselin EJ; Tony HP; Parker DC
J Immunol; 1988 Mar; 140(5):1408-13. PubMed ID: 3257975
[TBL] [Abstract][Full Text] [Related]
17. Involvement of anti-Ig-activated serine protease in the generation of cytoplasmic factor(s) that are responsible for the transmission of Ig-receptor-mediated signals.
Kishimoto T; Kikutani H; Nishizawa Y; Sakaguchi N; Yamamura Y
J Immunol; 1979 Oct; 123(4):1504-10. PubMed ID: 314462
[TBL] [Abstract][Full Text] [Related]
18. Anti-Ig-mediated proliferation of human B cells in the absence of protein kinase C.
Francois DT; Katona IM; June CH; Wahl LM; Feuerstein N; Huang KP; Mond JJ
J Immunol; 1988 May; 140(10):3338-43. PubMed ID: 3129493
[TBL] [Abstract][Full Text] [Related]
19. The phosphorothioic acid O-(2-chloro-2,3,3-trifluorocyclobutyl) O-ethyl S-propyl ester exacerbates organophosphate polyneuropathy without inhibition of neuropathy target esterase.
Moretto A; Bertolazzi M; Lotti M
Toxicol Appl Pharmacol; 1994 Nov; 129(1):133-7. PubMed ID: 7974486
[TBL] [Abstract][Full Text] [Related]
20. The inhibition of the mitogenic stimulation of B lymphocytes by a serine protease inhibitor: commitment to proliferation correlates with an enhanced expression of a cell-associated arginine-specific serine enzyme.
Ku GS; Quigley JP; Sultzer BM
J Immunol; 1983 Nov; 131(5):2494-9. PubMed ID: 6355295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
